Heavy-hitting MS Therapies Now Being Used Sooner for Some Patients
I’m sitting in Florida and the start of spring training is only about six weeks from now, so please forgive a baseball analogy: The heavy-hitters of the MS-fighting treatments, the monoclonal antibodiesĀ (mAbs), are moving up in the lineup. Five treatments currently are in the mAbs class:Ā Ocrevus,…